14 products of Patanjali, Divya Pharmacy banned in Noida
Noida, Jul 12: The sale of 14 Ayurvedic medicines manufactured by Divya Pharmacy and Patanjali Ayurveda Limited has been banned by the Gautam Buddh Nagar administration.
The Supreme Court on July 9 directed Patanjali Ayurved Ltd, founded by yoga guru Ramdev, to file an affidavit stating whether advertisements of its 14 products, whose manufacturing licences were initially suspended but later restored, have been withdrawn.
The Uttarakhand State Licensing Authority had on April 15 issued an order suspending the manufacturing licences of 14 products of Patanjali Ayurved Ltd and Divya Pharmacy.
The Regional Ayurvedic and Unani Officer of Gautam Buddh Nagar issued the directive banning the 14 products on Friday, officials said.
This action follows orders from the State Drug Licensing Authority, Ayurvedic and Unani Services, Uttarakhand, they said.
According to information shared by the district information office, all medical practitioners and medical stores operating in the district have been informed to cease the sale of the 14 listed products immediately.
The listed products include Swasari Gold, Swasari Vati, Bronchom, Swasari Pravahi, Swasari Avaleh, Mukta Vati Extra Power, Lipidom, Madhu Grit, BP Grit, Madhunashini Vati Extra Power, Livamrit Advance, Livogrit, Eyegrit Gold, and Patanjali Drishti Eye Drop.
"As per the orders of the State Drug Licensing Authority Ayurvedic and Unani Services, Uttarakhand, Dehradun, the manufacturing license for the attached list of 14 medicines of Divya Pharmacy and Patanjali Ayurveda Limited has been cancelled," Dr Dharmendra Kumar Kem, Regional Ayurvedic and Unani Officer Gautam Buddh Nagar, said.
"In pursuance of the above orders, all the drug dealers/medical stores working in the district are informed that the sale of the medicines mentioned in the attached list is banned with immediate effect. If found buying/selling the said medicines, action will be taken as per rules," Kem added in the order.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
India's external debt rises by USD 31 bn to USD 647 bn in 2023: World Bank report
India's total external debt has increased by USD 31 billion to USD 646.79 billion in 2023, according to World Bank International Debt Report.
The report said that interest payment increased from USD 15.08 billion in 2022 to USD 22.54 billion in 2023.
While the long-term debt stocks have risen 7 per cent to USD 498 billion in 2023, short-term debt stocks declined marginally to USD 126.32 billion in 2023.
According to the report, external debt stock as percentage of exports was 80 per cent, while debt servicing was 10 per cent of exports in 2023.
The World Bank International Debt Report, 2024, further said that net debt inflows during the year worked out to be USD 33.42 billion, while the net equity inflows were higher at USD 46.94 billion in 2023.
